Keith J. Page
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
NETSseq reveals inflammatory and aging mechanisms in distinct cell types, driving cerebellar decline in ataxia telangiectasia.
Journal: Frontiers in neuroscience
Published: May 28, 2025
Identification of a thermogenic target in the dorsal raphe nucleus for weight management in mice.
Journal: Nature communications
Published: July 30, 2024
Differential contribution of THIK-1 K+ channels and P2X7 receptors to ATP-mediated neuroinflammation by human microglia.
Journal: Journal of neuroinflammation
Published: November 16, 2023
Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses.
Journal: The Journal of experimental medicine
Published: November 11, 2022
Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasome.
Journal: Neuropharmacology
Published: August 18, 2022
Pharmacological targeting of glutamatergic neurons within the brainstem for weight reduction.
Journal: Nature metabolism
Published: September 23, 2021
Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors.
Journal: JCI insight
Published: June 18, 2021
The selective 5-HT1F receptor agonist lasmiditan inhibits trigeminal nociceptive processing: Implications for migraine and cluster headache.
Journal: British journal of pharmacology
Published: March 25, 2021
Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease.
Journal: The Journal of pharmacology and experimental therapeutics
Published: November 26, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026